{"name":"Lipomedix Pharmaceuticals Inc.","slug":"lipomedix-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Promitil","genericName":"Promitil","slug":"promitil","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"Promitil","genericName":"Promitil","slug":"promitil","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPeEE1VEp5OHM4NFBzM1RsRmRybmRwQzBTeHlUVE9GYnhKdy1NalVUcS1Cd2V0YlBFSEZpYWNmNGhfNm1iZ0F3VWdYTTd0aVZKaUpvQS1Edms2WE1sczRaUEFQTkFpcURjQ3o3LThIME5wUGU1SG1fejlxa19PYTBJaGFwMUJCM2xnQ3RyRTFoMjUtSW1YMlZINlJDdDhKWXZRNWd3UGdIX0JKTU5uQjhNclRSMlJWTXVUb0E?oc=5","date":"2024-08-22","type":"regulatory","source":"Fierce Biotech","summary":"While FDA mulls Zevra's rare disease med, Rafael merges with Cyclo to push their rival candidate - Fierce Biotech","headline":"While FDA mulls Zevra's rare disease med, Rafael merges with Cyclo to push their rival candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxOQTJjLUNXUnBSWWxMeERzRDRyM21TdHZKclVhbHYwdnVGYmVZVGphM3lLNVJEUVJuWk8yUkFuTmNTcThJVnVBZm44bHMxMzllREQ0Y0ZmUklHRVpoanpNUFFRcDJUTXA0ZHFmd1BLeDZNNGJiR21Ra3d4TnRtcC1PUWdsUHl0ZXYxYnk5Zk9YVDhDa1FCOGtBVU04RUs4OWp6UkRjemRiRUlrc283cHk5RzVMaGZGWnFEbHJ0bmRUU3ZTU29CMjV3UkV2b3ZhSXA4WV9fcDVKSXoxS1hVTDA3eDh1WGpkeElPUlZTYXhvdk5jbW9EdnFvV2ZxcXpZSTN5Rm1pV2dNT2ppNFFrVnc?oc=5","date":"2021-06-21","type":"deal","source":"PR Newswire","summary":"Rafael Holdings Announces Strategic Merger with Rafael Pharmaceuticals to Form a Focused Late-Stage Clinical Oncology Company - PR Newswire","headline":"Rafael Holdings Announces Strategic Merger with Rafael Pharmaceuticals to Form a Focused Late-Stage Clinical Oncology Co","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOY0lBUHlFeVdVd1BMNTFzTG5VQmI3dUUxM1VickpfZGQ4dG1UMlgzSU1mV2Z6cmVocnhGeDV2Y0tZbG5lWmRNcHMzVUtIS1VmcmpiVjR4aVhRbTVZemNrVEw0ZG1Oc3k3YWZHdFJ3TFc5VU12bFFIQXdCOWY5cHVsUURGdzltUmJJNXp6bU5oeG5uM1dq?oc=5","date":"2021-02-19","type":"pipeline","source":"drugdeliverybusiness.com","summary":"ForDoz enters manufacturing agreement with LipoMedix - drugdeliverybusiness.com","headline":"ForDoz enters manufacturing agreement with LipoMedix","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQSWhVWGdwZlExM0UtbnlQVHUzS0x0Z2h0RE1ZTzlHMDFaQk5pd3JmQnRKMHVPNnJZX3FqODV0clRiNEtrSXlvY2lEWEs4d0ZhYXpjMFlwWlFjandKeWQtbDRmbE5nY2dvWUhjeGRIRElLemt1TjFCMmlCeXY5dVdqY2t0UkhvSkZZUDN0dlZqR2kxeFlBZDlNanFkQWpmNU45aXQ2VDYwWQ?oc=5","date":"2020-01-13","type":"pipeline","source":"PR Newswire","summary":"Barer Institute Announces Founding Board Members - PR Newswire","headline":"Barer Institute Announces Founding Board Members","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOd0VDaGVzXzlnMGRsa1BfTHhqNENHTUI0ZlJ5VW1oZGpOSThjWEQtczFOLXhRT0Q5RGZnT2l3cFRpY0dzLXNvUDYtWWMwWHlpQ0JGdE5icnNaM2F0QlFaMnkxYy1EX0JpYnRPaW9ITW1FTTBZVUFKZ3JnWk1Tc3JrTFFEdkhuejB0TFQ4eHVWM1UxVzl6VEVQYmxpYWxjY0hrLUhLT3AwVUJ0SDhWSXlvbTNn?oc=5","date":"2019-01-23","type":"deal","source":"PR Newswire","summary":"Rafael Holdings Acquires Majority Stake in Rafael Pharma - PR Newswire","headline":"Rafael Holdings Acquires Majority Stake in Rafael Pharma","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"discontinued":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}